Skip to main content
AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. — Investor Relations & Filings

Ticker · AIM ISIN · US42366C3016 US Professional, scientific and technical activities
Open in API
Filings indexed 1,092 across all filing types
Latest filing 2026-06-11 Share Issue/Capital Cha…
Country US United States of America
Listing US AIM

About AIM ImmunoTech Inc.

https://aimimmuno.com/

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics for various diseases. The company's primary areas of focus include oncology, immune disorders, and viral diseases. Its lead drug candidate is Ampligen® (rintatolimod), a proprietary immuno-modulator with broad-spectrum activity demonstrated in pre-clinical testing. Ampligen® is being evaluated in multiple clinical studies for a range of debilitating and life-threatening conditions.

Recent filings

Filing Released Lang Actions
8-K
Share Issue/Capital Change Classification · 98% confidence The document is a Form 8-K “Current Report” filing, with the primary content being the Entry into a Material Definitive Agreement (a Securities Purchase Agreement) and the Unregistered Sales of Equity Securities, outlining the issuance of common stock and warrants in a registered direct offering and private placement. This is fundamentally an announcement of new share issues and related capital changes (equity financing activity). Therefore, the correct classification is Share Issue/Capital Change (SHA).
2026-06-11 English
8-K
Governance Information Classification · 90% confidence The document is a Form 8-K current report filed under Item 5.03 describing an amendment to the company’s bylaws, i.e., a change in internal governance rules. It is not announcing stock transactions, dividends, or board appointments but specifically details changes to the company’s internal governance framework. This matches the “Governance Information (CGR)” category.
2026-06-10 English
424B5
Capital/Financing Update Classification · 85% confidence The document is a Prospectus Supplement filed on Form 424(b)(5) as part of an SEC shelf registration on Form S-3, detailing a public offering of common stock, unregistered shares, pre-funded warrants, and placement agent arrangements. It is a financing document describing the terms of a capital raise rather than reporting financial results or governance changes. Therefore, it falls under Capital/Financing Update (CAP).
2026-06-10 English
S-1
Capital/Financing Update Classification · 92% confidence The document is a Form S-1 registration statement and preliminary prospectus under the Securities Act of 1933, detailing the offering and resale of shares, use of proceeds, underwriting, risk factors, and related financing structure. It is not an annual or quarterly report, management discussion, or proxy statement, but rather a capital raising document. Therefore it fits the Capital/Financing Update category.
2026-06-08 English
8-K
Report Publication Announcement Classification · 85% confidence The document is a Form 8-K current report delivering a Regulation FD disclosure. It does not include the substantive contents of any earnings, financial statements, or presentations; rather, it announces that a press release and an investor presentation slide deck have been released and furnished as exhibits or made available via links. Under the “menu vs. meal” rule, this is not the report itself but an announcement of its publication, matching the Report Publication Announcement (RPA) category.
2026-06-04 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K “Current Report” describing the entry into a Securities Purchase Agreement and Placement Agency Agreement for the issuance and sale of shares and warrants (unregistered sale of equity securities). This is a corporate fundraising/financing transaction rather than a full annual or quarterly report, call transcript, proxy statement, or dividend notice. Accordingly, it falls under the Capital/Financing Update category.
2026-05-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.